diaDexus, LLC
diaDexus is a diagnostics company, located in South San Francisco, California, focusing on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. diaDexus was formed in 1997 as a joint venture between SmithKline Beecham (now GlaxoSmithKline) and Incyte; upon formation, GSK granted diaDexus an exclusive license to certain diagnostic intellectual property, including the PLAC Test for Lp-PLA2. The PLAC Test is the only blood test cleared by the FDA to assess risk for coronary heart disease and ischemic stroke associated with atherosclerosis.
Contact Details
Office Address
diaDexus, LLC
349 Oyster Point Blvd., Ste. 10
South San Francisco, CA , USA 94080
Phone: (650) 624-1000
Fax: (650) 624-4785
Executives
President, CEO, and Director
Patrick Plewman
EVP, CFO, and Secretary
David J. Foster